Americans are increasingly using cryptocurrency to purchase peptides—drugs marketed as weight loss, muscle building, and anti-aging treatments. In the first quarter of 2026, sellers of such substances received $32 million in digital assets, demonstrating a massive 700% increase compared to the same period last year. These figures come from an analysis of on-chain transactions.

The peptide market is divided into two segments. Legal drugs that have undergone clinical trials are sold through major pharmacy chains. However, a significant portion of online trade falls into a gray zone: cheap analogs from foreign laboratories are delivered without a prescription or insurance, often labeled "not for human use."

Why Bitcoin Became the Currency of Choice

Traditional banks and payment systems refuse to work with such suppliers due to high compliance risks. As a result, many sellers accept payment exclusively in Bitcoin. Notably, for some buyers, this becomes their first experience with cryptocurrencies. For example, a 49-year-old marketer from the U.S., wanting to purchase retatrutide (an Eli Lilly drug), found a Chinese supplier who agreed to ship 20 vials for $240. On the American market, a similar purchase would have cost $300 monthly. The seller demanded payment only in digital assets, forcing the buyer to buy Bitcoin for the first time in his life.

Three Waves of Market Growth

Analytics reveal three key stages. Before 2025, it was a niche "underground" market with a monthly inflow of about $200,000. Then the topic came to the attention of the Make America Healthy Again movement, coinciding with the appointment of Robert F. Kennedy Jr. as head of the U.S. Department of Health and Human Services. However, a direct causal link is not evident from on-chain data.

A sharp spike occurred in late 2025 when the topic entered the TikTok subculture of looksmaxxing. The average monthly inflow quadrupled to $9.9 million, exceeding $10 million in peak months. The total annual turnover of this segment, according to various estimates, ranges from $100 million (data for 2023) to $41.4 million in 2025, a 20% increase from the previous year.

Major Players Shift to Stablecoins

The market is highly uneven. The bulk of transactions comes from a narrow group of large sellers with broad customer bases. Small suppliers use various coins, but major players have almost entirely switched to Bitcoin and stablecoins. Sellers with an average deposit of over $1,000 predominantly use "stablecoins"—this allows them to hedge volatility in large and cross-border purchases.

The Chinese Connection

The primary raw materials for peptides are produced in China. Chinese chemical companies are actively expanding their presence in this niche. Over three quarters of last year, imports from China to the U.S. roughly doubled to over $300 million. Some suppliers have transitioned to peptides from the drug trade. For instance, Bigreat Technology, which previously supplied fentanyl and amphetamine precursors to markets in Russia and Kazakhstan, now sells cosmetic peptides through a separate legal entity, Zhengzhou DEPU Technology.

My comment: The peptide market is a vivid example of how cryptocurrency fills niches inaccessible to traditional finance. However, a 700% annual growth rate and parallels with the early stages of Silk Road should alarm regulators. If the trend continues, we will see either stricter controls or the final transformation of this segment into a full-fledged shadow market with a multi-billion dollar turnover.